Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation.

Wu WC, Chiou YY, Hung HH, Kao WY, Chou YH, Su CW, Wu JC, Huo TI, Huang YH, Lee KC, Lin HC, Lee SD.

J Clin Gastroenterol. 2012 Oct;46(9):789-95.

PMID:
22941428
2.

Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.

Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Lin HC, Lee SD, Wu JC.

J Clin Gastroenterol. 2012 Jan;46(1):62-70. doi: 10.1097/MCG.0b013e31822b36cc.

PMID:
21934530
3.

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.

Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Wu JC, Huo TI, Huang YH, Wu WC, Lin HC, Lee SD.

Clin Radiol. 2012 May;67(5):429-36. doi: 10.1016/j.crad.2011.10.009. Epub 2011 Dec 6.

PMID:
22153231
4.

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.

Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST.

J Gastrointest Surg. 2008 Jan;12(1):183-91. Epub 2007 Sep 15.

PMID:
17874276
5.

Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.

Kikuchi L, Menezes M, Chagas AL, Tani CM, Alencar RS, Diniz MA, Alves VA, D'Albuquerque LA, Carrilho FJ.

World J Gastroenterol. 2014 Feb 14;20(6):1585-93. doi: 10.3748/wjg.v20.i6.1585.

6.

Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.

Chen PH, Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Chao Y, Lin HC, Wu JC.

Ann Hepatol. 2013 Mar-Apr;12(2):263-73.

7.

Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.

Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.

J Gastroenterol Hepatol. 2010 Mar;25(3):597-604. doi: 10.1111/j.1440-1746.2009.06125.x. Epub 2010 Jan 14.

PMID:
20074153
8.

[Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].

Wu J, Chen MH, Yang W, Wu W, Yan K.

Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):256-60. doi: 10.3760/cma.j.issn.1007-3418.2012.04.006. Chinese.

PMID:
22964144
9.

Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.

Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH, Lee HS.

Liver Int. 2013 Jul;33(6):884-93. doi: 10.1111/liv.12132. Epub 2013 Mar 5.

PMID:
23461618
10.

Impact of renal insufficiency on patients with hepatocellular carcinoma undergoing radiofrequency ablation.

Chen CF, Liu PH, Lee YH, Tsai YJ, Hsu CY, Huang YH, Chiou YY, Huo TI.

J Gastroenterol Hepatol. 2015 Jan;30(1):192-8. doi: 10.1111/jgh.12669.

PMID:
25039567
11.
12.

Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation.

Facciorusso A, Del Prete V, Antonino M, Neve V, Crucinio N, Di Leo A, Carr BI, Barone M.

J Gastroenterol Hepatol. 2014 Nov;29(11):1905-10. doi: 10.1111/jgh.12618.

PMID:
24731153
13.

Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patients.

Zhang L, Ge NL, Chen Y, Xie XY, Yin X, Gan YH, Zhang BH, Zhang JB, Chen RX, Wang YH, Ye SL, Ren ZG.

Med Oncol. 2015 Mar;32(3):77. doi: 10.1007/s12032-015-0532-z. Epub 2015 Feb 20.

PMID:
25698535
14.

Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis.

Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, D'Onofrio M, Martone E, Nicoli P, Iacono C.

J Gastrointest Surg. 2008 Jan;12(1):192-8. Epub 2007 Nov 13.

PMID:
17999123
15.

Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.

Cheung TT, Ng KK, Poon RT, Fan ST.

J Hepatobiliary Pancreat Surg. 2009;16(5):655-60. doi: 10.1007/s00534-009-0103-9. Epub 2009 Apr 17.

PMID:
19370304
16.

Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors.

Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF.

Eur J Radiol. 2008 Aug;67(2):336-47. Epub 2007 Aug 31.

PMID:
17765421
17.

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K.

Am J Gastroenterol. 2012 Apr;107(4):569-77; quiz 578. doi: 10.1038/ajg.2011.425. Epub 2011 Dec 13.

18.

Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma.

Fang Y, Chen W, Liang X, Li D, Lou H, Chen R, Wang K, Pan H.

J Gastroenterol Hepatol. 2014 Jan;29(1):193-200. doi: 10.1111/jgh.12441.

PMID:
24224779
19.

Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.

Toshikuni N, Takuma Y, Goto T, Yamamoto H.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2361-6. doi: 10.5754/hge12934.

PMID:
23169175
20.

The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.

Nishikawa H, Osaki Y, Iguchi E, Koshikawa Y, Ako S, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, Nasu A, Kita R, Kimura T.

J Clin Gastroenterol. 2013 Apr;47(4):359-66. doi: 10.1097/MCG.0b013e31826be9ad.

PMID:
23090049

Supplemental Content

Support Center